The study examined genetic alterations in more than 3,200 patients with lung cancer, focusing on key genes linked to ...

If you have non-small-cell lung cancer (NSCLC), your cancer might carry certain changes, or mutations, in your EGFR gene. Those changes make the protein made from this gene act in ways it shouldn’t.

Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

which is a genetic mutation that can be found in some patients with non-small cell lung cancer. After undergoing surgical resection, these patients will be randomly assigned to receive either V940 ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...

NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

Zorifertinib is the first drug in the world to launch a registration clinical trial specifically for advanced NSCLC with CNS metastases and achieve remarkable results. It is also the only* EGFR ...

An increasing number of non-smokers are being diagnosed with lung cancer for a variety of reasons. To better understand this ...

November is Lung Cancer Awareness Month, and early detection is in the air. According to the Centers for Disease Control, ...